Latest
All News
Reports
Events
Directory
Contact
More
Ratioing the resected gastric volume to the number of fired staplers predicts weight loss
GLP-1 drugs reduce surgery complications in patients with diabetes
Reduced complication-related costs and enhanced patient recovery using the Ezisurg Endostapler
Serotonin plays key role in the development of post-bariatric hypoglycaemia
Journal Watch 8/1/2024
Biomea Fusion announces first data on icovamenib-semaglutide combination study
MBX Biosciences announces positive phase 1 topline results for MBX 1416 for the treatment of PBH
Turkey bans swallowable gastric balloons
Variant Bio and Novo Nordisk sign multi-year research partnership to discover novel targets for metabolic disease
Younger adults face rising gastric cancer risk
New MRI technique identifies heart disease risk from fat composition
Genetically altered fat cells in mice show promise for obesity treatment
Calorie content influences food choices regardless of obesity status after surgery
Arrowhead initiates phase 1/2a study of ARO-INHBE for obesity
Rhythm gains expanded indication for IMCIVREE (setmelanotide) for patients as young as 2 years old
Zepbound (tirzepatide) is the first and only FDA approved prescription medicine for moderate-to-severe OSA in adults with obesity
BioAge axes STRIDES trial evaluating azelaprag in combination with tirzepatide for the treatment of obesity